Learning Objectives
Upon completion of this educational activity, participants should be able to:
- discuss the diagnosis of infectious diseases;
- explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs;
- discuss the latest information regarding risks, benefits, and cost-effectiveness of new and traditional diagnostic tests; and
- discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies.
Accreditation Statement
Relias LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Relias LLC designates this enduring material for a maximum of 3 AMA PRA Category 1 Credits™M. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3 MOC Medical Knowledge points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Financial Disclosure
Peer Reviewer Patrick Joseph, MD, is a consultant for Genomic Health Reference Laboratory, Siemens Clinical Laboratory, and CareDx Clinical Laboratory. Infectious Disease Alert’s Editor Stan Deresinski, MD, FACP, FIDSA, Updates Author Carol A. Kemper, MD, FACP, Peer Reviewer Kiran Gajurel, MD, Executive Editor Shelly Morrow Mark, Editor Jonathan Springston, and Editorial Group Manager Leslie Coplin report no financial relationships to this field of study.
